Tomuzotuximab is a fully human, glycoengineered IgG1 monoclonal antibody specifically targeting the Epidermal Growth Factor Receptor (EGFR). This recombinant antibody is engineered to bind selectively to EGFR, a receptor critically involved in the proliferation and survival of various cancer cells. By inhibiting EGFR signaling, Tomuzotuximab exhibits potent anticancer activities, making it a valuable tool for research in oncology and therapeutic development.
Tomuzotuximab is a fully human, glycoengineered IgG1 monoclonal antibody specifically targeting the Epidermal Growth Factor Receptor (EGFR). This recombinant antibody is engineered to bind selectively to EGFR, a receptor critically involved in the proliferation and survival of various cancer cells. By inhibiting EGFR signaling, Tomuzotuximab exhibits potent anticancer activities, making it a valuable tool for research in oncology and therapeutic development.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
